EA
CPIX icon

Emerald Acquisition’s Cumberland Pharmaceuticals CPIX Stock Holding History

Emerald Acquisition’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$26K Hold
5,198
– – ﹤0.01% 2932
2016
Q2 		$23K Buy
+5,198
New +$23.8K ﹤0.01% 2965

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Emerald Acquisition's CPIX Position: Q3 2016 in Review

Emerald Acquisition held its Cumberland Pharmaceuticals (CPIX) position steady in Q3 2016 at 5,198 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Emerald Acquisition first reported a position in CPIX in Q2 2016 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold CPIX as of Q3 2016.

  • Emerald Acquisition held 5,198 shares of Cumberland Pharmaceuticals worth $26K as of Q3 2016.
  • Emerald Acquisition left its Cumberland Pharmaceuticals share count unchanged in Q3 2016.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2932 holding.
  • Emerald Acquisition first reported a position in Cumberland Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.